ArticleAIDS research and therapy2026
Clinical outcomes after the implementation of a patient-centered care program applied to newly admitted people with HIV in Mexico City: a retrospective cohort study.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough antiretroviral therapy (ART) has improved life expectancy in people living with HIV (PWH), sustained HIV care remains a critical challenge. The Newly Admitted Patients Program (NAPP), a local Patient-Centered Care (PCC) intervention, was implemented for patients admitted via the HIV clinic. We aimed to evaluate clinical outcomes (loss to follow-up (LTFU), hospitalization, treatment discontinuation (TD), virologic failure, and mortality) among participants in NAPP versus non-participants (No-NAPP). MATERIALS AND
methodsWe conducted a retrospective cohort study at a single tertiary-care center, including PWH from January 2015 to December 2023. Participants were followed from enrollment in the HIV clinic to their last visit. Clinical, demographic, and laboratory variables were analyzed, and adjusted logistic regression was used to identify factors associated with clinical outcomes.
resultsWe included 758 participants: 387 (51.1%) in the NAPP group and 371 (48.9%) in No-NAPP. NAPP participants were younger (median age 32 vs. 37 years, p < 0.01), more often MSM (78% vs. 70.1%, p = 0.04), and education levels differed (p = 0.014), though university/postgraduate attainment was similar between groups (53.7% vs. 55.8%). At follow-up, the NAPP group had lower rates of LTFU (10.9% vs. 27.8%, p < 0.01), hospitalization (21.9% vs. 32.6% p < 0.01), and mortality (3.4% vs. 8.9%, p < 0.01). NAPP participation was independently associated with reduced risk of LTFU (OR = 0.32, 95% CI = 0.22-0.49), hospitalization (OR = 0.61, 95% CI 0.44-0.86), and death (OR = 0.42, 95% CI = 0.21-0.85).
conclusionsDespite similar virological and immunological characteristics at baseline, those who participated in NAPP intervention experienced fewer unfavorable clinical outcomes, highlighting the importance of PCC programs in improving health outcomes for PWH.
Indexed as
Identifiers
42366397What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.